REVIEW ONCOLOGY

Optimal management of pancreatic cancer: current standards and challenges for improving care and research

J.L. van Laethem

PRACTICE GUIDELINES

Opportunities and challenges in oncology and molecular testing: the Belgian strategy

A. Hébrant, E. Van Valckenborgh, R. Salgado, G. Froyen, F. Hulstaert, D. Roberfroid, S. Tejpar, A. Jouret-Mourin, M. Van den Bulcke, A. Waeytens

Prevention of chemotherapy-induced nausea and vomiting: Belgian antiemetic treatment options anno 2018

W. Lybaert, P. Clement, K. Punie, J. Mebis, M. Renard, H. Wildiers

Second-line treatment of non-small cell lung cancer adenocarcinoma patients not harbouring an oncogene driver mutation anno 2017–2018: A consensus group meeting

P-E. Baugnée, L. Bosquée, C. Compère, N. D’Haene, I. Demedts, D. Galdermans, P. Germonpré, M. Gustin, V. Ninane, S. Ocak, P. Pauwels, T. Pieters, A. Sadowska, A. Sibille, V. Surmont, J. Vansteenkiste

PHARMACOTHERAPY

How to overcome resistance to epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer?

J. Raskin, B.I. Hiddinga, A. Janssens, P. Pauwels, J.P. Van Meerbeeck

ONCOCASE

Primary leiomyosarcoma of the thyroid: case report and review of the literature

E. Verhelst, S. De Schepper, S. Declercq, D. Schrijvers

ONCOTHESIS

Exploring extracellular vesicles for siRNA delivery and Raman-based diagnostics

S. Stremersch, S. De Smedt, K. Braeckmans, K. Raemdonck

CONGRESS NEWS

Highlights of Scientific Summits Meeting

M. Waterschoot, B. Hermans, M. Claessens, K. Decaestecker, G. De Meerleer, L. Goeman, S. Joniau

REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier